Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tecnovax is an Argentine animal-health biotechnology company focused on the development, manufacture, and commercialization of vaccines and immunotherapies for livestock, equines, companion animals, and aquatic species. The company markets commercial vaccine lines including Providean for ruminants, Contendor for horses, Viratec for dogs and cats, and Aquatec for aquatic animals, and states that it has administered more than one billion doses globally. In addition to its marketed veterinary biologics portfolio, Tecnovax provides tailored vaccines from field isolates and contract manufacturing services for third parties. The business is positioned as a regional leader in animal-health vaccines in Argentina and has international reach across more than 24 countries. Its operations are centered on prevention of infectious diseases affecting production animals and pets rather than human therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tecnovax.